Table 4 Characteristics of ART in HIV/AIDS patients treated with ART in Guangxi between 2003 and 2019
Variables | Total (%) (n = 1860) | HR (%) (n = 218) | non-HR (%) (n = 1642) | χ2/Z | P |
|---|---|---|---|---|---|
Time between HIV diagnosis and ART initiation (days) (Median, IQR) | 18 (8, 64.75) | 19 (7, 71.75) | 18 (8, 64) | −0.119 | 0.905 |
ART regimen at ART initiation |  |  |  | – | 0.419 |
 NRTI | 15 (0.81) | 2 (0.92) | 13 (0.79) |  |  |
 NRTI + NNRTI | 1628 (87.53) | 186 (85.32) | 1442 (87.82) |  |  |
 NRTI + PI | 164 (8.82) | 21 (9.63) | 143 (8.71) |  |  |
 NRTI + INSTI | 8 (0.43) | 0 (0.00) | 8 (0.49) |  |  |
 NNRTI | 13 (0.70) | 3 (1.38) | 10 (0.61) |  |  |
 NNRTI + PI | 23 (1.24) | 5 (2.29) | 18 (1.10) |  |  |
 PI | 9 (0.48) | 1 (0.46) | 8 (0.49) |  |  |
ART modification | Â | Â | Â | 6.577 | 0.010 |
 Yes | 155 (8.33) | 28 (12.84) | 127 (7.73) |  |  |
 No | 1705 (91.67) | 190 (87.16) | 1515 (92.27) |  |  |
Times of ART modification |  |  |  | – | 0.011 |
 0 | 1705 (91.67) | 190 (87.16) | 1515 (92.27) |  |  |
 1 | 139 (7.47) | 28 (12.84) | 111 (6.76) |  |  |
 2 | 14 (0.75) | 0 (0.00) | 14 (0.85) |  |  |
 3 | 2 (0.11) | 0 (0.00) | 2 (0.12) |  |  |
ART interruption |  |  |  | – | 0.117 |
 Yes | 1 (0.05) | 1 (0.46) | 0 (0.00) |  |  |
 No | 1859 (99.95) | 217 (99.54) | 1642 (100.00) |  |  |
Cotrimoxazole use during ART | Â | Â | Â | 23.136 | < 0.001 |
 Yes | 506 (27.20) | 89 (40.83) | 417 (25.40) |  |  |
 No | 1354 (72.80) | 129 (59.17) | 1225 (74.60) |  |  |
Total | 1860 (100.00) | 218 (11.72) | 1642 (88.28) | Â | Â |